SPOTLIGHT -
What to Expect if MDMA-Assisted Psychotherapy Gets Approved by the FDA
Learn more about the potential of MDMA-assisted psychotherapy.
Research and Opportunities at the 2024 ASCP Annual Meeting
Erin Crown, MHS, PA-C, shares her thoughts on ASCP, the annual meeting, and more.
Seltorexant for Major Depressive Disorder With Insomnia Symptoms Sees Positive Results
Research on MDD treatments seltorexant and Spravato (esketamine) CIII nasal spray shared at 2024 ASCP Annual Meeting.
A Voice Lab Gives Voice to the Psychoexemplary of Support
How does the Voice Lab relate to psychotherapy?
Tips for Managing Multiple Medication Use
An expert shares 7 principles for clinicians to consider when prescribing multiple medications for a patient.
Austedo XR Approved: A New Treatment Option for Tardive Dyskinesia and Huntington Disease
The FDA has approved Austedo XR as a once-daily pill treatment option for tardive dyskinesia and Huntington disease chorea control.
Early Improvement of Symptoms in Bipolar 1 Depression
Anita H. Clayton, MD, gives a preview of her upcoming poster presentation at the 2024 ASCP Annual Meeting.
Pseudospecific and Transdiagnostic Symptom Targeting in Clinical Trials
Joseph F. Goldberg, MD, gives a preview of his upcoming panel presentation at the 2024 ASCP Annual Meeting.
Exciting Possibilities at ASCP 2024
Anita H. Clayton, MD, welcomes us all to the 2024 ASCP Annual Meeting!
Onyda XR: The First and Only Liquid Nonstimulant ADHD Medication
Onyda XR is the first and only liquid nonstimulant ADHD medication approved in the US and the only approved nonstimulant ADHD medication with nighttime dosing.
Two Tales of Death, Depression, and Suicide in Athletes
What can 2 recent deaths show us about depression and suicidality?
Efficacy of Semaglutide for the Treatment of Substance Use Disorders
An analysis presented at the ASCP Annual Meeting explored the safety and tolerability of the treatment for alcohol and tobacco use disorders.
Polypharmacy in Older Adults
Clinicians should carefully weigh the risks and benefits of each prescribed medication for an older adult with neuropsychiatric diseases and periodically review all prescribed medications. Learn more here.
Psychedelics Safety Poll
Answer a quick question on psychedelics!
Efficacy of Brexpiprazole and Sertraline for the Treatment of PTSD
A poster at the 2024 ASCP Annual Meeting shared data from 3 randomized clinical trials on the safety and tolerability of this treatment combination.
The Social Determinants of Health—Social Psychiatry’s Basic Science
From populations to patients.
Understanding the Effects of Pharmacotherapy Through Passive Data Collection
An expert discusses the potential of smartphones as treatment measurement tools at the 2024 ASCP Annual Meeting.
Neuroplasticity After Brain Injury: Principles and Methods for Postinjury Improvement
Improving cognitive function is a primary goal of brain injury rehabilitation and is made possible through the process of neuroplasticity.
Efficacy of Modafinil for Treatment of Neurocognitive Impairment in Bipolar Disorder
An expert discusses the role of cognition in bipolar disorder and the potential of modafinil as a treatment for it at the 2024 ASCP Annual Meeting.
Revisiting Modafinil/Armodafinil for the Treatment of Bipolar Disorder
An expert shares some lessons learned from prior research on the treatment and suggestions for a way forward at the 2024 ASCP Annual Meeting.
Psychedelics Recent Research Poll
Navigating New Treatments for PTSD
An expert shares highlights from her panel presentation at the 2024 ASCP Annual Meeting.
Correlates of Antipsychotic Polypharmacy in Taiwanese Patients With Schizophrenia
What are the risks and benefits of antipsychotic polypharmacy for the treatment of schizophrenia?
Peacemaking as a Primary Psychoexemplary
In what ways can we make peace?
New Research: Revealing the True Duration of Binge-Eating Disorder
Investigators at McLean Hospital found 61% and 45% of individuals still experiencing binge-eating disorder after 2.5 and 5 years after their initial diagnoses, respectively.
Poster Preview: ASCP 2024
Attending the 2024 ASCP Annual Meeting? Be sure to catch these upcoming poster presentations.
Securing the Future of Lithium Research
How can we enhance our lithium research?
Hero
"...yet all the passengers filed out saying, “Thank you! We didn’t know a doctor would still help in an emergency.” But I was like the heroes on the evening news declaring, “No big deal. Just doing my job,” and meaning it..."
Longitudinal Study Looks at Risk of Cardiovascular Disease With Long-Term ADHD Medication Use
A study assessed the associations between the use of ADHD medications and CVD over the course of 14 years. Here's what the investigators found.
The Week in Review: May 20-24
Here are highlights from the week in Psychiatric Times.
